GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoTherapy Science Inc (TSE:4564) » Definitions » Shares Buyback Ratio %

OncoTherapy Science (TSE:4564) Shares Buyback Ratio % : -24.81 (As of Dec. 14, 2024)


View and export this data going back to 2003. Start your Free Trial

What is OncoTherapy Science Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. OncoTherapy Science's current shares buyback ratio was -24.81%.

OncoTherapy Science Shares Buyback Ratio % Historical Data

The historical data trend for OncoTherapy Science's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoTherapy Science Shares Buyback Ratio % Chart

OncoTherapy Science Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16.35 - -9.25 - -12.98

OncoTherapy Science Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.27 -5.32 - - -24.81

OncoTherapy Science Shares Buyback Ratio % Calculation

OncoTherapy Science's Shares Buyback Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Mar. 2023 ) - Shares Outstanding (EOP) (A: Mar. 2024 )) / Shares Outstanding (EOP) (A: Mar. 2023 )
=(192.644 - 217.644) / 192.644
=-12.98%

OncoTherapy Science's Shares Buyback Ratio for the quarter that ended in Sep. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Mar. 2024 ) - Shares Outstanding (EOP) (A: Sep. 2024 )) / Shares Outstanding (EOP) (A: Mar. 2024 )
=(217.644 - 271.644) / 217.644
=-24.81%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoTherapy Science Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of OncoTherapy Science's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoTherapy Science Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoTherapy Science Inc (TSE:4564) » Definitions » Shares Buyback Ratio %
Comparable Companies
TSE:4583 TSE:2385 TSE:4594 TSE:2342 TSE:4591 TSE:4570 TSE:4576 TSE:4584 TSE:4896 TSE:4596 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
11th Floor, Kanagawa Science Park R&D, 3-2-1 Sakado, Kanagawa, Kawasaki, JPN, 213-0012
Website
http://www.oncotherapy.co.jp
OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.

OncoTherapy Science Headlines

No Headlines